Individuals with 17-beta-hydroxysteroid dehydrogenase type 3 (17β-HSD3) deficiency face a multitude of challenges, primarily concerning genital appearance, potential malignancy risks, and fertility issues. Here, HSD17B3 is linked to hyperinsulinemic hypoglycemia, familial, 4.